[Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Contraception, fertilite, sexualite

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12280202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.

  1984cited by this paper
• The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male

  1982cited by this paper
• Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy.

  1982cited by this paper
• Male gonadal dysfunction in Hodgkin's disease. A prospective study.

  1981cited by this paper
• The influence of radiation on fertility in man.

  1980cited by this paper
• Pregnancy after chemotherapy for Hodgkin's disease.

  1979cited by this paper
• Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function.

  1979cited by this paper
• Pregnancy outcome of patients treated for Hodgkin's disease. A controlled study

  1978cited by this paper
• Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.

  1977cited by this paper
• Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkinapos;s disease

  1976cited by this paper
• Consequences of radiotherapy and antineoplastic therapy for the fetus.

  1976cited by this paper
• Fetal Renal Malformation Following Treatment of Hodgkin's Disease During Pregnancy

  1975cited by this paper
• Normal pregnancy in multiple myeloma treated with cyclophosphamide

  1974cited by this paper
• Sterility and testicular atrophy related to cyclophosphamide therapy.

  1972cited by this paper
• Cyclophosphamide and reproductive function.

  1972cited by this paper
• Alkylating agents and human spermatogenesis.

  1971cited by this paper
• Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents.

  1971cited by this paper
• Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease.

  1970cited by this paper
• Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma

  1970cited by this paper
• Long-term cyclophosphamide therapy in rheumatoid arthritis.

  1968cited by this paper

• The need for reproductive and sexual health discussions with adolescent and young adult cancer patients.

  2013cites this paper
• Breast cancer during pregnancy

  2010cites this paper
• Susceptibility of the human LNCaP prostate cancer cells to the apoptotic effect of marina crystal minerals (MCM) in vitro.

  2009cites this paper
• Saccharomyces cerevisiae, the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice

  2008cites this paper
• MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin.

  2008cites this paper
• In Vivo Tumor Inhibitory Effects of Nutritional Rice Bran Supplement MGN-3/Biobran on Ehrlich Carcinoma-Bearing Mice

  2008cites this paper
• Yeast therapy for the treatment of breast cancer: a nude mice model study.

  2007cites this paper
• Modified arabinoxylan rice bran (MGN-3/Biobran) enhances yeast-induced apoptosis in human breast cancer cells in vitro.

  2005cites this paper